Read more about the latest developments in MS research, treatments and specialist care, plus the latest updates on our work and the efforts of our amazing supporters
The MS Trust sends out a weekly news alert which includes the latest updates from the MS Trust, latest news, blogs and a news feed from MS in the Media.
Read our latest news
- Stem cell study for people with highly active relapsing MS shows promising results
- Caroline Wyatt talks about stem cell treatment
- Siponimod secondary progressive MS results published in Lancet
Results from a large clinical trial of siponimod for secondary progressive MS (SPMS) have been published. Those taking siponimod had a 21% reduced risk of progression.
Sarah has signed up to take part in Miles for MS, our new distance challenge fundraising event. She tells us why she'll be walking 100 miles in May.
When Yvonne adopted her dog Bonnie, she could never have imagined the positive difference she’d make to her life. Last year Yvonne trained Bonnie up to become an Assistance Dog, and the benefits have been endless, as she explains in this guest blog.
Preliminary data from an international stem cell study for people with relapsing multiple sclerosis has reported that those having stem cell treatment had fewer relapses and improved disability levels.
A few years after her diagnosis of multiple sclerosis, Elaine had to come to terms with using a wheelchair. In this inspirational guest blog she discusses her own journey of acceptance, the reaction of others, and the positive and negative sides of life in a wheelchair.
- Calnexin increases number of immune cells crossing blood-brain barrier
- My wife has MS and is no longer interested in any sexual contact
- Zinbryta withdrawn due to safety fears
- Sunshine exposure reduces MS risk
- Paralympian with MS
- Unsuccessful trial of PPMS drug
- Oily fish and risk of MS
- EBV prevalence
- Deaths associated with neurological conditions
- Radio play about MS
The manufacturers of Zinbryta (daclizumab) announce worldwide withdrawal of Zinbryta following new reports of serious side effects
- Think Hand campaign launched
- ACTRIMS conference review
- The work of the MS Brain Bank
The MS Trust has launched a programme to pioneer a new role in MS services: Advanced MS Champions. But what difference will these champions make to people living with advanced MS?
Up to 5,000 people with advanced MS will benefit from a new project launched at the House of Lords.
The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
Will I end up in a wheelchair?’ is often one of the first questions people ask when they are diagnosed with MS. For most people, the answer is NO, but if your mobility is affected by MS, you may find that a wheelchair - or other walking aid – actually gives you the freedom to continue doing the things you love and overcome some of the barriers MS presents, as Jerry explains in this guest blog.
- Encouraging stem cell results
- Tysabri and reducing relapse risk in pregnancy
- Stigma and depression
Increasing numbers of young people are being affected by MS - either because they have the disease themselves, or because a family member has been diagnosed. There isn’t enough reliable, accessible information to help them understand their condition. We’re determined to change this. But we need your help.
When Anna was told that she might have MS, she wanted to focus her energies on something positive and decided to climb the highest mountain in Wales.